Healthtech funding in Q3 2010

European Healthtech startup funding raised during Q3 2010.

In Q3 2010, 15 European Healthtech companies closed 15 funding rounds and raised €80M in equity funding (excluding debt and grants), up 35.0% versus Q3 2009. UK led by capital raised, and Amundi Private Equity Funds was the most active investor. Data as of 6 Nov 2026.

Equity funding

€80M

+35.0% vs Q3 2009 · excl. debt & grants

Funding rounds

+150.0% vs Q3 2009

Companies

Top country

Rank among sectors

11.2% of sector funding

Top-10 round share

95.5%

of disclosed capital

Funding by month

€ raised vs rounds, by month

Data table

	Funding	Rounds
Jul	€48M	6
Aug	€4.4M	2
Sep	€27M	7

Top countries

by € raised

Data table

	Healthtech — top countries by capital, Q3 2010
UK	€28M
France	€25M
Israel	€14M
Germany	€10M
Switzerland	€1.3M
Denmark	€1.0M
Spain	€42k

Stage mix

by € raised

Data table

	Healthtech — stage mix, Q3 2010
Series A	€29M
Series C	€21M
Early VC	€14M
Series B	€10M
Other	€5.7M
Seed	€394k

Top deals

largest disclosed rounds in Q3 2010

Company	Stage	Date	Amount
Kymab	Series A	Jul 2010	€25M
EarlySense	Series C	Jul 2010	€11M
uTest_Vamsi	Series C	Sep 2010	€10M
Protagen	Series B	Sep 2010	€10M
Global Imaging Online	Early VC	Jul 2010	€4.8M
Alyotech	Early VC	Jul 2010	€4.0M
Camero;Inc	Early VC	Aug 2010	€3.1M
WiThings	Series A	Sep 2010	€3.0M
Anaconda Pharma	Other	Jul 2010	€2.9M
Phagenesis	Other	Sep 2010	€2.8M
InSphero	Series A	Aug 2010	€1.3M
Reapplix	Early VC	Sep 2010	€1.0M
Acuitas Medical	Early VC	Jul 2010	€856k
Scopis	Seed	Sep 2010	€394k
Masquemedicos	Other	Sep 2010	€42k

View all 15 Healthtech deals in Q3 2010 →

Top investors

most active in Q3 2010, by deal count

← All 2010 Healthtech funding